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CysteinerCNT2 is a purine-preferring concentrative nucleoside transporter implicated in the regulation of
extracellular adenosine levels and purinergic signaling. This study addressed the analysis of the
CNT2 C-terminus tail as a domain likely to be implicated in transporter sorting. The topological
mapping of this segment revealed that Cys615 and Cys649 are important residues for the proper
trafﬁcking of CNT2 to the plasma membrane. The inhibition of protein disulﬁde isomerase (PDI)
and ER glycosidase I and II impaired rCNT2 trafﬁcking to the cell surface, similarly to Cys615 and
Cys649 mutants. The present work suggests these two cysteine residues are relevant for the proper
sorting of the transporter and its functional performance.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction and nucleoside-derived drug pharmacokinetics [8,9]. In otherCNT2. (SLC28A2) is the sodium-coupled purine-preferring
nucleoside transporter. Its purine selectivity makes CNT2 impor-
tant for the uptake of Ribavirin, a wide spectrum antiviral drug
used in Hepatitis C therapy, and anticancer drugs like Cladribine
and Clofarabine, used in leukemia therapy [1,2]. Several polymor-
phic variants, both at the promoter and coding sequences within
the SLC28A2 gene, have been identiﬁed so far. Some of these vari-
ants appear to be related to changes in ribavirin pharmacokinetics
[3–6]. CNT2 is expressed in most epithelial and immune system
cells. In (re)absorptive epithelia, this transporter is mostly located
at the apical domain [7] what leads to an asymmetrical distribu-
tion of concentrative (CNT-type) and equilibrative (ENT-type)
nucleoside transporter proteins. This asymmetry allows the
establishment of a transepithelial ﬂux of natural nucleosides and
nucleoside derived drugs, contributing to nucleoside homeostasisepithelial cells, like liver parenchymal cells, CNT2 is also located
at the sinusoidal (basolateral) membrane, where it is likely to con-
tribute to purinergic regulation by modulating extracellular aden-
osine levels [10,11]. CNT2 localization and expression is tightly
regulated by nutrients, cytokines and substrate availability [12–
14]. Besides, CNT2 activity is transiently up-regulated by adeno-
sine 1 receptor (A1R) activation in hepatocytes and neuronal cells
[15,16]. In fact, rCNT2 mRNA expression is high in rat nephron and
brain regions where A1R is abundant, thereby supporting a func-
tional interaction between the adenosine transporter and receptor
[17,18]. A role for CNT2 in metabolic regulation has also been sug-
gested, based on the ﬁnding that extracellular adenosine trans-
ported via CNT2 activates adenosine monophosphate kinase
(AMPK), a key pathway in metabolism [19]. Interestingly, the only
proteins known so far to interact directly with the intracellular N-
terminal tail of rCNT2 are the glycolytic enzyme aldolase B and the
glucose-dependent chaperone and member of the disulﬁde isom-
erase family ERp57/GRP58, both somehow implicated in energy
metabolism [20].
Although domains within the rCNT2 N-tail likely to contribute
to the regulatory events mentioned above are not known, two
motives have been reported to be important for rCNT2 sorting to
the plasma membrane in polarized and non-polarized cells. Thus,
the E25-E28 motif is important for the transporter turnover at
the plasma membrane and its membrane insertion whereas the
casein kinase 2 (CK2) phosphorylation site, S46LKD, is implicated
I. Pinilla-Macua et al. / FEBS Letters 588 (2014) 4382–4389 4383in the polarized insertion of the transporter in the apical mem-
brane of epithelial cells [21].
Membrane proteins contain a signal sequence that directs the
nascent peptide to the ER, where the co-translational translocation
occurs [22,23]. Numerous ER-residing enzymes and chaperones aid
in structural and conformational maturation [24]. Glycosylated
proteins are covalently modiﬁed by the attachment of a preformed
oligosaccharide that will tag the protein to its following matura-
tion stage, glycosidase I and II process this oligosaccharide so the
incipient glycoprotein can be recognized by Calnexin–Calreticulin
system and thus complete its ER-maturation [25–28]. In fact, this
system incorporates thiol isomerases and determines the fate of
the newly synthesized proteins [29–32].
These maturation processes are mostly related to endoplasmic
reticulum (ER) intraluminal domains of membrane proteins which
are facing the extracellular milieu once the protein is inserted into
the plasma membrane. In this regard, rCNT2 possesses a large
extracellular C-terminal tail which was predicted to be glycosyl-
ated [33]. This extracellular tail has been poorly studied; however,
it is likely to contain other regulatory sites relevant for its ER
export and proper sorting to the plasma membrane. Thus, the
aim of this study is to functionally map the extracellular C-termi-
nal domain of rCNT2.
2. Materials and methods
2.1. Chemicals and reagents
Guanosine, Dithiotreinol (DTT), Castanospermin and Bacitracin
were purchased from Sigma (Saint Louis, Missouri). [3H]-Guano-
sine was from Hartmann Analytic GmbH. The WGA-TRITC mem-
brane marker was obtained from Molecular Probes (Carlsbad, CA,
USA) and Aqua-poly/mount coverslipping medium was from Poly-
sciences, Inc (Warrington, PA, USA).
2.2. Cell culture and transfection
The CHO-K1 cell line was routinely cultured in EMEM medium
supplemented with 5% Fetal Bovine Serum (FBS), 1% mixture ofTable 1
















rC2 C596S Fw CCCAG
rC2 C596S Rv AAATT
rC2 C614S Fw AACCT
rC2 C614S Rv GGAAG
rC2 C615S Fw CCTATG
rC2 C615S Rv CTCTG
rC2-C649S YFP Fw CCTCA
rC2-C649S YFP Rv CAGTG
rC2-C650S YFP Fw CCTCA
rC2-C650S YFP Rv CAGTG
rC2-C658S YFP Fw CCTCTA
rC2-C658S YFP Rv CCGGTantibiotics (100 U/ml penicillin G, 0.1 mg/ml streptomycin and
0.25 lg/ml Fungizone), 2 mM glutamine, 0.1 mM non-essential
amino acids and 1 mM sodium pyruvate. All reagents were pur-
chased from Invitrogen (Carlsbad, CA, USA). Cells were maintained
at 37 C/5% CO2. No endogenous CNT2 activity is detected in these
cells.
CHO-K1 cells were transiently transfected with the plasmids
described below using Lipofectamine 2000 (Invitrogen, Carlsbad,
CA, USA) following the manufacturer’s protocol. Nucleoside trans-
port assays and analysis of the transporter wild type and mutants
(see below) using confocal microscopy were carried out 48 h after
transfection.
Treatment with Castanospermin (125 nM) and Bacitracin
(3 mM) were performed for 24 h prior uptake and immunoﬂuores-
cence protocol.
2.3. Generation of rCNT2 truncated and mutant constructs
rCNT2-YFP generated as described previously [21] was used as a
template for site-directed mutagenesis to generate C-terminal
truncations and cysteine mutants. Speciﬁc primer sequences are
shown in Table 1. All constructs were veriﬁed by DNA sequencing
with Big Dye Terminator sequencing kit v.3.1 (Applied Biosystems,
Foster city, CA, USA) and used for transient transfection.
2.4. Nucleoside transport assay
Nucleoside transport activity was monitored in cultured CHO-
K1 cells in either Na+ containing or Na+-free medium as previously
described [34].
2.5. Confocal microscopy imaging
To determine the localization of each construct, confocal
microscopy of YFP fused proteins was performed on sub-conﬂuent
monolayers of transfected CHO-K1 cells cultured on glass cover-
slips. Glass coverslips-grown cells were rinsed tree times with
phosphate buffered saline (PBS) supplemented with 0.1 mM of
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20 mM glycine. To analyze plasma membrane localization, WGA-
TRITC was used at 1 lg/ml for 10 min at room temperature after
ﬁxation, then rinsed three times in PBS and mounted with aqua-
poly/mount coverslipping medium.
Sections were viewed using a Leica TCS SP5 laser scanning
confocal microscope (Leica Microsystems Heidelberg GmbH,
Manheim, Germany) equipped with a DMI6000 inverted micro-
scope, argon laser, diode-pumped solid-state (561 nm), and a
63 oil immersion objective lens (NA 1.4) was used. Image
processing was performed with ImageJ software (NationalFig. 1. Effect of rCNT2 C-terminal tail deletions on activity and sorting. (A) Scheme
Concentrative [3H]-guanosine uptake measured in transiently transfected CHO-K1 show
activity whereas the intermediate construct (rCNT2-T605Stop) shows no signiﬁcant
constructs in transiently transfected CHO-K1 cells. Plasma membrane is labeled with W
constructs (YFP) and plasma membrane label (TRITC) along a representative line (merge
are normalized to rCNT2 uptake rates and expressed as means ± SEM of quadruplicate
assessed using Student’s t test: ⁄⁄⁄P < 0.001.Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.-
nih.gov/ij/).
2.6. Data analysis
Data are expressed as the mean ± SEM (standard error of the
mean) of uptake values obtained from triplicates of at least three
independent experiments carried out on different days on different
cells passages. Statistical analysis was performed using GraphPad
Prism version 5.03 for Windows (GraphPad Software, San Diego,
CA). Statistical differences were assessed using the unpairedof the rCNT2 C terminal tail truncated constructs sub-cloned in pEYFP-C1. (B)
s that both full C-terminal deletion and last 16aa deletion result in a 70% loss of
difference to rCNT2 transporter. (C) Subcellular localization of rCNT2 truncated
GA-TRITC (red). Histograms showing relative ﬂuorescence intensity of both rCNT2
image) that cross the cell support the different distribution of YFP-constructs. Data
measurements from three to eight independent assays. Statistical signiﬁcance was
Fig. 2. Effect of rCNT2 intermediate C-terminal tail deletions on activity. Uptake
assays where performed in CHO-K1 cells transiently transfected with intermediate
deletions between rCNT2-delC and rCNT2-T605Stop (A) and between rCNT2-
T605Stop and S642Stop constructs (B). Data are normalized to rCNT2 uptake rates
and expressed as means ± SEM of quadruplicate measurements from three to eight
independent assays. Statistical signiﬁcance was assessed using Student’s t test to
rCNT2: ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001.
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signiﬁcant.Fig. 3. C-terminal domain is enriched in conserved Cys residues some of which are in
Highlighted in grey are the last 5aa of the predicted TMD13, and in black the conserve
uptake in CHO-K1 cells transiently expressing rCNT2. Data are normalized to rCNT2 upta
independent assays.3. Results
3.1. The extracellular C-terminal tail of rCNT2 contains regulatory
signals
Three sequential deletions were done in the C-tail to map
potential regulatory domains, rCNT2delC, rCNT2-T605Stop and
rCNT2-S642Stop, deleting 69, 55 and 18 amino acids, respectively
(Fig. 1A). The expression ratios of these truncated transporters,
when compared to control (wild type rCNT2) showed similar ﬂuo-
rescence levels (data not shown). Thus, changes in uptake values
are likely to correspond either to different intrinsic activity of the
transporter protein and/or to differential subcellular localization.
The expression of rCNT2delC and rCNT2-S642Stop resulted in a
75% reduction of guanosine uptake compared to wild type,
whereas no signiﬁcant effect on substrate uptake was observed
when rCNT2-T605Stop, an intermediate deletion, was expressed
(Fig. 1B). Changes in the activity of rCNT2delC and rCNT2-S642Stop
were associated with different subcellular localization of the trun-
cated proteins, showing in both cases ER missorting. Accordingly,
rCNT2-T605Stop sorting to the plasma membrane was not signiﬁ-
cantly affected (Fig. 1C).
To further understand the differences in activity and localiza-
tion described above, two more deletions were done between
rCNT2delC and rCNT2-T605Stop (segment 1) and between
rCNT2-T605Stop and rCNT2-S642Stop (segment 2) (Fig. 1A). Seg-
ment 1 deletions showed a progressive increase in uptake activity
as the tail length increased (Fig. 2A), whereas those within seg-
ment 2 showed no signiﬁcant changes in substrate uptake com-
pared to the rCNT2-S642Stop construct (Fig. 2B). Taken together,
these data suggest that rCNT2 requires a C-t with a minimal length
of 16aa to trafﬁc to the plasma membrane. Moreover, this extracel-
lular domain contains motifs in the last 55aa that may be regulat-
ing rCNT2 exit from ER.
3.2. rCNT2-dependent substrate uptake is sensitive to reducing agents
The analysis of the sequence fraction corresponding to the pre-
dicted C-tail showed highly conserved Cys residues among CNT2oxidized state in functional rCNT2. (A) Sequence alignment of CNT1-3 orthologs.
d Cys residues. (B) Effect of time course DTT treatment (5 mM) on [3H]-guanosine
ke rates and expressed as means ± SEM of quadruplicate measurements from three
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(Fig. 3A). The oxidative status of rCNT2 was monitored in a DTT
time course assay. The reducing agent DTT (5 mM) caused a loss
of rCNT2-mediated activity with time, reaching a residual activity
equivalent to 30% of that present in untreated cells (Fig. 3B). No
effect was observed in the endogenous ENT activity (data not
shown). This data supports the view that CNT2 activity depends
on its oxidative state, in which the extracellular cysteine residues
may play a role.
3.3. Cys615 and Cys649 play a role in the export of rCNT2 to the plasma
membrane
To validate the implication of Cys residues within the C-termi-
nal region in the redox state of CNT2, all the 6 Cys within this
domain were substituted for Ser. Only C615S and C649S single
mutants showed a signiﬁcant decrease in substrate uptake (50%
reduction of activity) and their intracellular location was dramati-Fig. 4. Identiﬁcation a potential interaction between Cys615-Cys649. (A) Sodium-depende
single and double Cys to Ser mutants (C615S, C649S and C615S/C649S). (B) Subcellula
membrane is labeled with WGA-TRITC (red). Histograms showing relative ﬂuorescence in
representative line (merge image) that cross the cell support the different distribution
means ± SEM of quadruplicate measurements from three to eight independent assays
⁄⁄⁄P < 0.001.cally affected. Histograms of the subcellular distribution of these
two mutants are consistent with signiﬁcant ER retention (Fig. 4A
and B).
Based on these observations, the double mutant, C615S/C649S,
was generated to study the effect of combined cysteine mutants on
CNT2 activity. The double mutant showed similar biological activ-
ity to that found for single mutants, C615S and C649S (50% of
rCNT2) (Fig. 4A). Thus, ER export to the plasma membrane of single
mutants, C615S and C649S, is deﬁcient compared to the wild-type
transporter but equivalent to that of the double mutant C615S/
C649S. Histograms revealed that under these conditions of trans-
porter overexpression, some plasma membrane insertion still
occurred, thereby contributing to the observed uptake activity
(Fig. 4B).
However, the residual uptake activity was higher than that
observed after DTT treatment, thereby implying that there may
be other residues responsible for the complete redox state of
CNT2 (Fig. 4A).nt [3H]-guanosine uptake (1 lM for 1 min) in CHO-K1 transiently transfected with
r localization of Cys mutants correspond with the variable uptake activity. Plasma
tensity of both rCNT2 constructs (YFP) and plasma membrane label (TRITC) along a
of YFP-constructs. Data are normalized to rCNT2 uptake rates and expressed as
. Statistical signiﬁcance was assessed using Student’s t test to rCNT2: ⁄P < 0.05;
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efﬁcient structure and export
The involvement of the ER quality control system in rCNT2 mat-
uration and sorting to the plasma membrane was studied using
inhibitors of Glycosidase I-II and protein disulﬁde isomerase
(PDI), castanospermin and bacitracin, respectively. Cells expressing
rCNT2 treated with castanospermin, as described in Section 2.2,
showed a 40% loss in transport activity and signiﬁcant relocation
of the transporter to the ER (Fig. 5A and B). On the other hand, bac-
itracin treatment (described in Section 2.2) caused even a more
pronounced loss of transporter function and, similarly to castano-
spermin, transporter retention in the ER (Fig. 5A and B). The same
treatments in cells expressing the double mutant C615S/C649S
showed additional effect neither in basal uptake activity nor in
their intracellular location, thereby suggesting that these mutants
were already identiﬁed as defective proteins (Fig. 5A and B).
4. Discussion
This study addressed the mapping of the extracellular tail of
rCNT2 in an attempt to determine which conserved residues in this
domain, if any, could contribute to transporter maturation and
sorting to the plasma membrane. Our ﬁndings anticipate that
two conserved cysteines within this fragment of the protein
(Cys615 and Cys649) might be relevant for that purpose.
Substituted Cysteine-Accessibility Method (SCAM) has been
very helpful for the structural study of many transporter proteins.
As discussed above, in most cases, these cysteine-less mutantsFig. 5. Inhibition of ER quality control enzymes lead to a similar phenotype as disulﬁde br
for 1 min) in CHO-K1 transiently transfected with rCNT2 wild-type and C615S/C649S d
(3 mM). (B) Subcellular location of rCNT2 and rCNT2-C615S/C649S double mutant was a
expressed as means ± SEM of quadruplicate measurements from three to eight independe
or to Castanospermin treated (+) rCNT2: ⁄P < 0.05; ⁄⁄P < 0.01.appear to retain enough activity, when expressed in oocytes, as
to allow this type of analysis. In the case of nucleoside transporters,
the hCNT3 cysteine-less protein is functional and has been used to
map hCNT topology as well as to identify putative residues rele-
vant for function [35,36]. However, when the hCNT3 cysteine-less
mutant was expressed in Xenopus laevis oocytes, it appeared to
induce reduced activity (less than 50%) when compared to the wild
type transporter protein [35]. The evidence that this cysteine-less
protein is still functional does not necessarily rule out the possibil-
ity of selected cysteines being implicated in the ﬁne regulation of
transporter protein trafﬁcking in a mammalian cell background.
For instance, the human Multidrug Resistance Protein 1 (hMRP1)
cysteine-less mutant has been shown to be functional when
expressed in yeast, but its trafﬁc has been reported to be severely
compromised when expressed in human cells [37].
In this study, the comprehensive mapping of the C-terminus tail
of rCNT2 revealed a possible coordination between two segments
of the C-tail, comprised between 605–642aa and 642–658aa,
which might be somehow contributing to the proper sorting of
the transporter to the plasma membrane. Experiments using the
reducing reagent DTT suggested that a fully functional rCNT2
needs to be in an oxidized form, being cysteine residues likely to
play a role in this phenomenon. In fact, sequence alignment shows
that the extracellular C-terminal domain of the protein (last 71aa)
includes 6 cysteine residues conserved among orthologs and
within the SLC28 gene family as well. Indeed, site directed muta-
genesis of extracellular Cys residues within this segment was per-
formed and Cys615 and Cys649 were identiﬁed as important
residues to reach full (WT equivalent) rCNT2 biological activity.idge disruption. (A) Sodium-dependent [3H]-guanosine uptake was measured (1 lM
ouble mutant after 24 h treatment with Castanospermin (125 nM) and Bacitracin
ssayed after treatments. Data are normalized to rCNT2 untreated uptake rates and
nt assays. Statistical signiﬁcance was assessed using Student’s t test to untreated (*)
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where it is included (rCNT2-E617Stop, rCNT2-M629Stop and
rCNT2-S642Stop) led to a signiﬁcant loss of function and localiza-
tion, probably due to the disruption of a potential structure of
the tail; however, when the minimum fragment that includes both
cysteine residues (rCNT2-T605Stop) is deleted, no effect on activity
is reported even though substitution of the target cysteines (615
and 649) impairs substrate uptake and localization This observa-
tion suggests that basic rCNT2 function is not dependent on the
expression of a full length C-t tail as referred for prokaryotes; but
the fact that mammalian CNTs include a long C-t tail and that
the relevant cysteine residues identiﬁed in the present work are
highly conserved, suggest a regulatory mechanism probably
through the structure of the C-tail.
Extracellular cysteines have been implicated in the proper mat-
uration and sorting to the plasma membrane of different types of
transporters and receptors. For instance, this appears to be the case
for mOAT1, hOCT1, hOCT2, OATP2B1 and P2 type receptors, such as
P2X7, among others [38–42] . Extracellular cysteines might be
implicated in disulﬁde bonds, which appear to be crucial for traf-
ﬁcking and, in some cases essential for oligomerization, as recently
reported for the cysteines in the ﬁrst big extracellular loop of hOCT
proteins [39,40].
The recent crystallization of the Vibrio cholerae CNT suggests
that it is structured as a trimer [43]. Residues implicated so far in
the trimerization, which are conserved in hCNTs, have been local-
ized in TM3, TM6, and IH1, without yet any apparent involvement
of disulﬁde bridges. Moreover, the V. cholerae ortholog lacks the
extracellular C-tail, where cysteines here identiﬁed as helpful for
proper transporter sorting are located. Based upon these observa-
tions we speculate that extracellular C-t tail might confer addi-
tional properties to the transporter (and highly likely to the three
members of the CNT protein family) which might affect the
dynamics of the sorting process but not the process itself, as the
deletion mutant rCNT2-T605Stop can indeed promote a nearly
wild type transporter activity. Extracellular domains of transmem-
brane proteins are facing the lumen during their maturation in the
ER. This orientation implies that these domains may contain post-
translational motifs involved in the maturation and export of the
newly synthesized proteins [24]. Most of these surface proteins
are glycoproteins and the addition of the preformed N-glycan to
the Asn residues functions as a targeting signal for maturation
processes [25,28]. One of the critical steps in protein folding is
the formation and isomerization of disulﬁde bounds, function that
is performed by ERp57, a PDI associated to the calnexin/calreticulin
system. The rCNT2 maturation process appears to require its entry
into the calnexin/calreticulin cycle to acquire its C-terminal struc-
tured conformation, as suggested by the inhibition of Glycosidase
I-II with castanospermin [44,45] and ERp57 with Bacitracin [46].
Moreover, once the protein maturation is impaired by the substitu-
tion of critical cysteine residues, no further effects are observed
when the ER quality control system is inhibited.
In conclusion, this study suggests that rCNT2 Cys615 and Cys649
are implicated in the maturation of the transporter probably by
structuring the last 55aa of the C-t tail, through the entrance of
the transporter into the calnexin–calreticulin cycle. Because the
deletion of these last 55aa of the C-t tail does not appear to impair
function, we propose that the structure of this last segment might
be involved in regulatory mechanisms that will be further studied.Funding
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